Related Experiment Video
Updated: Aug 15, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
The case for hormone replacement: new studies that should inform the debate
1Section of Women's Health, Women's Health Center, The Cleveland Clinic Foundation, OH 44195, USA. thackeh@ccf.org
Cleveland Clinic Journal of Medicine
|September 12, 2002
Summary
Hormone replacement therapy (HRT) risks may outweigh benefits for older women, but it can effectively treat vasomotor symptoms and potentially depression. Low-dose HRT offers similar efficacy with fewer side effects.
Area of Science:
- Reproductive Endocrinology
- Geriatric Medicine
- Pharmacology
Background:
- The Women's Health Initiative (WHI) study indicated risks of hormone replacement therapy (HRT) exceeded benefits in postmenopausal women.
- The WHI did not specifically evaluate HRT's efficacy for vasomotor symptom relief.
- Emerging research suggests potential benefits of HRT for mood and symptom management.
Purpose of the Study:
- To re-evaluate the efficacy of hormone replacement therapy (HRT) in managing specific menopausal symptoms.
- To compare the effectiveness and side effect profiles of low-dose versus standard-dose HRT.
- To explore the potential role of genetic testing in personalizing HRT treatment.
Main Methods:
- Review of existing literature and clinical trial data on hormone replacement therapy (HRT).
- Analysis of studies comparing low-dose and standard-dose HRT regimens.
- Examination of research on HRT's impact on depression and vasomotor symptoms.
- Consideration of genetic markers for predicting HRT response.
Main Results:
- Low-dose HRT demonstrates comparable efficacy to standard-dose HRT in symptom relief.
- Low-dose HRT is associated with a reduced incidence of adverse side effects.
- Evidence suggests HRT may offer benefits for managing depression in some women.
- HRT is not recommended for primary cardiovascular risk reduction.
Conclusions:
- Hormone replacement therapy (HRT) remains a viable option for vasomotor symptom management in postmenopausal women.
- Low-dose HRT presents a favorable risk-benefit profile compared to standard doses.
- Further research into personalized medicine, including genetic testing, may optimize HRT utilization.
Related Concept Videos
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...